Fan Li, MD, MS, and Zhousheng Xiao, MD, PhD. “Fibroblast Growth Factor 23 As a Potential Target for Treatment”. Nephrology, Jan. 2025, pp. 1-6, doi:10.17140/npoj.2025.v9.i01.pp01-06.2212.